
Nova Cannabis Inc. (TSX: NOVC.TO) AI-Powered Stock Analysis
See how Nova Cannabis Inc. scores across key metrics like financial growth, valuation, and market position on the TSX, using AI-driven evaluation.
NOVC.TO●TSX
HealthcareMedical - Pharmaceuticals
$1.74
$0.01(0.57%)
Canadian Market opens in 21h 19m
Nova Cannabis Inc. (TSX: NOVC.TO) AI-Powered Stock Analysis
See how Nova Cannabis Inc. scores across key metrics like financial growth, valuation, and market position on the TSX, using AI-driven evaluation.
Model Information
The AI Stock Analysis Model is provided for informational purposes only and should not be considered financial advice. We are continuously improving this model to increase accuracy and performance.Read our Full DisclaimerNova Cannabis Inc. (TSX: NOVC.TO) Stock Overall Grade
Nova Cannabis Inc.'s grade for its TSX listing, based on a comprehensive AI analysis of financial metrics, growth potential, and market position.
Z
Grade Breakdown by Metric
See how each financial and market factor contributes to Nova Cannabis Inc.'s overall TSX stock rating.
Forecast
C+Score
55/100Financial Growth
CScore
40/100Fundamental Growth
C+Score
50/100Key Ratios
B+Score
73/100Sector Comparison
B+Score
75/100Industry Comparison
C+Score
50/100S&P 500 Benchmark
A+Score
97/100Analyst Consensus
C+Score
50/100Nova Cannabis Inc. (TSX: NOVC.TO) AI-Powered Stock Analysis
On the TSX, NOVC.TO demonstrates Good performance with an overall Forecast Score of 55/100 (C+), reflecting weak confidence in its potential. Financial Growth (40/100, C) and Fundamental Growth (50/100, C+) highlight its stability, while Key Ratios (73/100, B+) and Sector Comparison (75/100, B+) indicate solid positioning. Compared to broader benchmarks like the S&P 500 (97/100, A+), the TSX-listed stock shows competitive strength. Analyst Consensus (50/100, C+) suggests High divergence in outlook.(TSX: NOVC.TO) Component Analysis Explained
Understand the key factors behind each Nova Cannabis Inc. (TSX: NOVC.TO) stock grade, including financials, comparisons, and forecasts.